A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases
Clinical trial NCT05042791 · UNKNOWN
Trial details
- NCT number
- NCT05042791
- Sponsor
- Jiangxi Provincial Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2025-09-30
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.